Page 300 - Clinical Small Animal Internal Medicine
P. 300

268  Section 3  Cardiovascular Disease


  VetBooks.ir


                                                                     ARVC
                                                                  RA, RV dilation
                                       HCM
                                    phenotype
                                                                             Dietary taurine
                                                                              deficiency

                           Increased LV wall thickness                           Tachycardia-mediated
                                                                                   cardiomyopathy
                                                         End-stage
                                                           HCM     DCM
                                                          Systolic  phenotype
                                                         dysfunction Chamber dilation,
                                                                   systolic
                                                                  dysfunction
                                                           RCM
                                                         phenotype  ?Unclassified
                                                         Normal LV,
                                                         LA dilation  Abnormalities not
                                                                    fitting other
                                                                    categories

               Hypertension
                             Acromegaly  “Transient  Hyperthyroidism        Anemia
                                        myocardial
                                        thickening”

            Figure 27.1  Myocardial disease phenotypes. There is overlap in the cardiac characteristics between the different “classic” forms of
            cardiomyopathy, and it can be difficult to differentiate cardiomyopathies with a genetic or unknown etiology from cardiomyopathies
            caused by systemic disease on the basis of cardiac characteristics alone. Hypertrophic cardiomyopathy (HCM) is defined as left ventricular (LV)
            hypertrophy in the absence of an obvious cause, but hypertension, acromegaly, “transient myocardial thickening,” and hyperthyroidism
            can all result in a phenotype that is identical to classic HCM. A minority of cats with severe (primary) HCM develop systolic dysfunction,
            and are described as “end‐stage HCM,” overlapping with dilated cardiomyopathy (DCM). A DCM phenotype can be produced by taurine
            deficiency or a tachycardia‐mediated cardiomyopathy though no underlying cause is found in most cats with dilation of all four cardiac
            chambers and global systolic dysfunction. The classic form of restrictive cardiomyopathy (RCM) is defined as normal LV dimensions with
            biatrial enlargement, but there is overlap with the above phenotypes. Not all cats fit into one of the categories listed above. Those with
            predominantly right heart enlargement without an obvious cause are usually presumed to be arrhythmogenic right ventricular cardiomyopathy
            (ARVC), but others do not fit any category and are sometimes called “unclassified cardiomyopathy” or “non-specific phenotype”.


            HCM
                                                              in left atrial (LA) pressures and acute pulmonary edema.
            Key pathologic features of HCM include increased LV   The cats with subclinical HCM that are most vulnerable
            mass associated with myocyte disarray, interstitial myo-  to these stressors are likely to be those with LA enlarge-
            cardial fibrosis, and narrowing of small coronary arter-  ment. Cats with massive LV hypertrophy may also be at
            ies.  Myocardial  hypertrophy  may  result  in  delayed  LV   increased  risk,  but  the  relationship  between  LV  wall
            relaxation, but this is usually well tolerated under normal   thickness and risk is not linear, and LA enlargement is a
            circumstances and is not likely to result in clinical signs.   better global indicator of advanced disease.
            Many cats with HCM will remain clinically stable pro-  Many cats with well‐compensated HCM exhibit
            vided  they  are  not  subjected  to  a  sudden  change  in   dynamic  LV  outflow  tract  obstruction,  which  can  be
            hemodynamic load. Examples of such triggers include   either persistent or only induced by excitement/exertion.
            the stress of a visit to the veterinarian, which increases   Outflow tract obstruction is usually caused by systolic
            myocardial oxygen demand; general anesthesia, which   anterior motion (SAM) of the mitral valve, where move-
            can reduce cardiac output; or intravenous fluid therapy,   ment of the anterior mitral leaflet towards the interven-
            which can result in volume loading. Any of these short‐  tricular septum during mid to late systole causes
            term hemodynamic stressors can cause a sudden increase   obstruction to ejection of blood flow, as well as mitral
   295   296   297   298   299   300   301   302   303   304   305